New Federal Contractors — August 05, 2026

Leidos won a $318.4 million BPA call from U.S. Customs and Border Protection for IT application development support for traveler processing vetting software. With $184.3 million (58%) already outlayed within the first year of a 2.75-year period, this signals rapid contract ramp and low execution risk, providing an estimated $115.8 million in annual revenue.

TriWest secured a $983.9 million firm-fixed-price delivery order from the VA for direct health insurance services, but the performance period is only one month (June 2026). This creates a potential near-term revenue catalyst if executed, but also introduces significant revenue recognition risk given the compressed timeline.

Icahn School of Medicine at Mount Sinai received a $186.2 million cost-no-fee contract from the CDC for a Clinical Center of Excellence. While the 8-year duration provides stable revenue, the cost-no-fee structure means zero profit margin, limiting financial upside for the institution.

TriWest Healthcare Alliance's $983.9M VA contract has a one-month performance period (June 2026). Any delay in service commencement or billing could result in a material revenue shortfall, as zero funds have been outlayed to date.

The digest shows extreme concentration risk: 58% of total obligation value ($983.9M of $1.71B) is tied to a single one-month contract with TriWest. A failure or protest could disproportionately impact the aggregate picture.

The Leidos DHS/CBP contract was awarded under full and open competition, meaning it could be re-competed at the May 2027 end date. Competitors may challenge the award or bid aggressively for the follow-on.

The $983.9M VA contract to TriWest signals sustained or increased federal spending on veteran healthcare benefits. Investors should monitor for follow-on contracts or extensions, which could provide a multi-year revenue stream for health insurance administrators.

Leidos' $318.4M DHS/CBP task order for traveler vetting software indicates strong demand for IT modernization in homeland security. This could lead to additional task orders or expansions, especially given the 58% outlay rate.

The $186.2M CDC contract to Icahn School of Medicine, with a potential $340.8M value over 8 years, suggests stable funding for clinical research and healthcare services. This could signal opportunities for other academic medical centers or healthcare providers.

The digest shows zero defense contracts but $1.71B in civilian awards, with 69% ($983.9M) going to VA health insurance and 19% ($318.4M) to DHS/CBP IT services. This indicates robust non-defense federal spending, particularly in healthcare benefits and border security technology.

The TriWest $983.9M contract has a one-month performance period, creating a binary outcome: either rapid revenue recognition or significant disruption. This contrasts with the Leidos 2.75-year task order, which provides stable, predictable revenue.

{"entity" => "TriWest Healthcare Alliance Corp.", "reason" => "The $983.9M VA contract has a one-month performance period with zero outlayed funds, creating high execution risk and potential for a material revenue event.", "trigger" => "June 2026 performance completion; any contract modifications or extensions; outlayed funds tracking"}

{"entity" => "Leidos, Inc.", "reason" => "The $318.4M DHS/CBP task order is 58% outlayed, indicating strong execution. The May 2027 end date creates a re-compete catalyst.", "trigger" => "May 2027 contract end date; any protest filings; DHS budget allocations for vetting software"}

{"entity" => "Icahn School of Medicine at Mount Sinai", "reason" => "The $186.2M CDC contract has an 8-year duration with options up to $340.8M. Option exercises will signal funding stability.", "trigger" => "Option exercise announcements; CDC budget allocations for clinical research"}